BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 15319449)

  • 1. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
    Mynard V; Latchoumanin O; Guignat L; Devin-Leclerc J; Bertagna X; Barré B; Fagart J; Coqueret O; Catelli MG
    Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
    Kovalovsky D; Refojo D; Liberman AC; Hochbaum D; Pereda MP; Coso OA; Stalla GK; Holsboer F; Arzt E
    Mol Endocrinol; 2002 Jul; 16(7):1638-51. PubMed ID: 12089357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
    Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
    Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.
    Mynard V; Guignat L; Devin-Leclerc J; Bertagna X; Catelli MG
    Endocrinology; 2002 Oct; 143(10):3916-24. PubMed ID: 12239103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone or dexamethasone regulates rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter.
    Murakami I; Takeuchi S; Kudo T; Sutou S; Takahashi S
    J Endocrinol; 2007 May; 193(2):279-90. PubMed ID: 17470519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs.
    Kovalovsky D; Paez Pereda M; Labeur M; Renner U; Holsboer F; Stalla GK; Arzt E
    FEBS Lett; 2004 Apr; 563(1-3):229-33. PubMed ID: 15063754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment.
    Maira M; Martens C; Batsché E; Gauthier Y; Drouin J
    Mol Cell Biol; 2003 Feb; 23(3):763-76. PubMed ID: 12529383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein.
    Jin WD; Boutillier AL; Glucksman MJ; Salton SR; Loeffler JP; Roberts JL
    Mol Endocrinol; 1994 Oct; 8(10):1377-88. PubMed ID: 7854355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW; Ren SG; Melmed S
    J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of niemann-pick c1 gene expression by the 3'5'-cyclic adenosine monophosphate pathway in steroidogenic cells.
    Gévry NY; Lalli E; Sassone-Corsi P; Murphy BD
    Mol Endocrinol; 2003 Apr; 17(4):704-15. PubMed ID: 12554781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism between Nur77 and glucocorticoid receptor for control of transcription.
    Philips A; Maira M; Mullick A; Chamberland M; Lesage S; Hugo P; Drouin J
    Mol Cell Biol; 1997 Oct; 17(10):5952-9. PubMed ID: 9315653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
    Bousquet C; Ray DW; Melmed S
    J Biol Chem; 1997 Apr; 272(16):10551-7. PubMed ID: 9099700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW; Ren SG; Melmed S
    Ann N Y Acad Sci; 1998 May; 840():162-73. PubMed ID: 9629248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
    Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
    Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.
    Rambaud J; Desroches J; Balsalobre A; Drouin J
    J Biol Chem; 2009 May; 284(21):14147-56. PubMed ID: 19321449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells.
    Philips A; Lesage S; Gingras R; Maira MH; Gauthier Y; Hugo P; Drouin J
    Mol Cell Biol; 1997 Oct; 17(10):5946-51. PubMed ID: 9315652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible binding of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein (CREB) to a cAMP-responsive promoter in vivo.
    Wölfl S; Martinez C; Majzoub JA
    Mol Endocrinol; 1999 May; 13(5):659-69. PubMed ID: 10319317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.